The 36-year-old is perhaps the very best pitcher in the entire sport when healthy, but maintaining his health has been a struggle over the past half decade. After winning back-to-back NL Cy Young awards with the Mets in 2018 and ’19 and finishing third during the shortened 2020 season, deGrom got off to an unbelievable start in 2021 with a 1.08 ERA and an eye-popping 45.1% strikeout rate. Unfortunately, he was sidelined in early July with forearm and elbow issues that ultimately ended his season. It’s been more of the same ever since, with deGrom making increasingly brief appearances in the majors each year but nonetheless continuing to dominate whenever he’s on the mound.

Since the start of the 2021 season, deGrom has pitched to a 2.01 ERA (200 ERA+) with a 1.63 FIP and 307 strikeouts in 197 1/3 innings. That would be on a shortlist for the greatest pitching seasons of all time if it hadn’t taken deGrom parts of four seasons to accumulate those numbers, and after watching Jordan Montgomery and Max Scherzer depart from their rotation in back-to-back offseasons the Rangers are surely hoping that they’ll get to see what deGrom can do over a full slate of starts this year. That’s something deGrom is fully on board with, as he told reporters (including McFarland) yesterday that his goal is to make 30 starts this year.

While McFarland notes that deGrom has not yet spoken to Rangers brass about his workload for 2025, the idea of a pitcher with deGrom’s injury history making 30 starts can’t be entirely dismissed. After all, southpaw Garrett Crochet made 32 starts with the White Sox last year despite not having pitched more than 65 innings in a season throughout college and his entire professional career due to injuries and time spent in the bullpen. The White Sox made that possible by aggressively managing his innings throughout the second half. He never recorded an out in the fifth inning this year after the calendar flipped to July and his pitch count maxed out at 77 after the All-Star break. Crochet, of course, is more than a decade younger than deGrom, but this sort of aggressive innings management could allow the Rangers to utilize their ace all throughout the regular season and into the playoffs without him needing to throw anything close to 200 innings.

deGrom isn’t the only key player for the Rangers who is hoping for better health in 2024. McFarland relays that third baseman Josh Jung, outfielder Evan Carter, and shortstop Corey Seager are all healthy and ready for Spring Training next month after undergoing surgeries in the fall. Seager underwent sports hernia surgery back in September but resumed baseball activities in November, while Jung and Carter are on a slightly more delayed timeline after undergoing wrist and back surgery respectively in October.

That trio being healthy and effective in 2025 would be a huge boon for the Rangers who failed to defend their 2023 World Series title in the 2024 postseason in large part thanks to a lackluster offense. Rangers hitters produced a collective wRC+ of just 95 last year as Seager was limited to 123 games by injuries while Jung and Carter managed just 46 and 45 games respectively. Seager remained as effective as ever when healthy enough to take the field with a .278/.353/.521 slash line in 533 trips to the plate, but Jung (102 wRC+) and especially Carter (80 wRC+) struggled to keep up with their expected production even when they were on the field due to the nagging nature of their injuries.

While the club has augmented its offense this winter by bringing in Joc Pederson and Jake Burger to replace Nathaniel Lowe in the lineup, better health from Jung and Carter figure to be necessary if the Rangers hope to look more like their 2023 offense, which was third in baseball with a 116 wRC+, than their below-average 2024 club in the upcoming season. Healthy seasons from Jung and Carter would also come with the benefit of pushing outfielder Leody Taveras and infielder Josh Smith into bench roles, giving them one of the deeper positional groups in the sport when fully healthy.

Sept. 10: Jacob deGrom makes his season debut on Friday. The Rangers announced that the two-time Cy Young winner will start that evening’s game in Seattle. It will be his first major league appearance since April 2023. deGrom underwent Tommy John surgery last June.

While deGrom’s return comes too late to give Texas any hope of a playoff push, it’s part of what should be a very exciting series. The Rangers will turn to top prospect Kumar Rocker for his MLB debut in Thursday’s opener. deGrom goes the following night. Manager Bruce Bochy told the beat this evening that Max Scherzer will be reinstated from the 15-day injured list to start on Saturday (X link via Shawn McFarland of the Dallas Morning News). Texas will need to create space on the 40-man roster for both Rocker and deGrom.

deGrom has gotten through four rehab starts within the past few weeks. He has mowed down minor league hitters, striking out 15 while allowing only five baserunners over 10 2/3 innings. deGrom tossed four scoreless innings in just 49 pitches with Double-A Frisco on Saturday. Kennedi Landry of MLB.com wrote over the weekend that the Rangers had envisioned deGrom throwing somewhere around 60 pitches in that outing, though they ultimately elected to cap him at four innings when he pitched so efficiently. That could point to a potential 65-75 pitch count during this week’s start.

The Rangers should get three or four starts from deGrom before the end of the season. They’re not going to be of much significance in the standings (beyond the indirect effect of playing the Mariners, a fringe contender, at least once). Getting deGrom back for a few starts should at least give the pitcher and the front office some comfort going into the offseason. deGrom had battled a handful of arm issues late in his Mets tenure. He only managed six starts and 30 1/3 innings with Texas before suffering the significant elbow injury.

Few players are more important to the Rangers’ hope of a return to contention in 2025. deGrom may still be the best pitcher on the planet when healthy. He was utterly dominant for the Mets when he was able to pitch. He’d carried that form over in his first month in a Texas uniform, working to a 2.67 earned run average while striking out almost 40% of batters faced.

deGrom is going into the third season of a five-year, $185MM free agent deal. He’ll make $40MM next season, followed by successive salaries of $38MM and $36MM through 2027. The Tommy John surgery triggered a conditional team option in his deal for 2028. That’s valued at $20MM, though deGrom could push it to $30MM if he finishes in the top five in Cy Young balloting in any of the next three years.

Scherzer, meanwhile, has been out since the start of August because of a shoulder issue. He’d also missed most of the season’s first half rehabbing offseason back surgery and battling a nerve problem in his throwing hand. Scherzer has been limited to eight starts this season, turning in a 3.89 ERA across 39 1/3 innings. The future Hall of Famer will be a free agent next offseason. Scherzer has already declared he intends to continue pitching; he’ll be one of the top risk/reward plays in the starting pitching class.

“If it all goes well, he’ll be pitching for us next time around,” manager Bruce Bochy told MLB.com’s Kennedi Landry and other reporters.  “It’s pretty cool because it’s been a long road as these guys go through the rehab on the Tommy John.”

DeGrom had his Tommy John surgery in June 2023, and last pitched in a big league game on April 28, 2023.  After signing a five-year, $185MM free agent contract with Texas during the 2022-23 offseason, deGrom’s only contribution to the Rangers’ World Series season was six starts and 30 1/3 innings, albeit with a very impressive 2.67 ERA and his typically excellent strikeout and walk rates.

Statistics compiled during minor league rehab stints should always be taken with a grain of salt, but deGrom has looked quite sharp in posting an 0.84 ERA over 10 2/3 total innings in the minors.  As Landry noted, deGrom has been so dominant that he hasn’t been able to entirely hit his assigned rehab checkpoints.  In his start on Saturday, Bochy said deGrom was assigned for four innings or 60 pitches, yet deGrom breezed through Double-A opponents on just 49 pitches — the most he has thrown in any of his four rehab starts.

As the season enters its final three weeks, the Rangers’ title defense has resulted in only a 70-74 record and a longshot bid at a wild card berth.  DeGrom won’t be returning to a pennant race, but there’s some obvious benefit in getting back on a big league mound and shaking off some rust in advance of a hopefully normal offseason, and then a standard ramp-up in Spring Training.  At age 36 and with just 186 2/3 MLB innings pitched since Opening Day 2021, deGrom’s health history will always make him something of a question mark, yet he has continued to deliver whenever he has been able to pitch.

DeGrom could soon be joined by another veteran ace in Max Scherzer, whose minor league rehab stint got underway Saturday at Triple-A with four hitless innings of work on 53 pitches.  Right shoulder fatigue and then triceps discomfort has kept Scherzer on the injured list since the start of August, but a mechanical fix seems to have corrected his triceps issue, and Scherzer looked to be in good form on Saturday.

It seems possible that Scherzer could rejoin the Rangers as early as this week’s road trip, depending on whether or not the team feels he needs any more rehab work to more fully build his pitch count.  The Rangers could also activate Scherzer and then allow him to rebuild at the MLB level, either on a limited innings count or with a piggyback pitcher working behind Scherzer.

Heading into the season, Texas planned to have deGrom, Scherzer (who was then recovering from offseason back surgery), and Tyler Mahle (Tommy John surgery) all back around the middle of the year, providing the rotation with some reinforcements down the stretch.  While a few setbacks delayed these pitchers on that projected timeline, the bigger problem was other injuries and a lack of hitting that torpedoed the Rangers’ season.

Ironically, this planned surplus of pitching has now come at a time when the Rangers might prefer to look at their future arms.  One such hurler is top prospect Kumar Rocker, who has opened some eyes since his own return from a May 2023 Tommy John surgery.  The third overall pick of the 2022 draft has an 0.46 ERA over 19 2/3 innings in Double-A ball this season, and an 1.80 ERA in 10 innings since being promoted to Triple-A Round Rock.

These numbers have been impressive enough that Rangers GM Chris Young told reporters (including Evan Grant of the Dallas Morning News) that the team hadn’t closed the door on the possibility of Rocker making his big league debut at some point before the 2024 campaign is over.  Grant ran through the various factors involved, including Rocker’s rough 50-inning cap in his first season back from TJ surgery, and the fact that Texas would be putting Rocker on the 40-man roster perhaps earlier than necessary.  With three weeks remaining in the season, there’s still time for Rocker to bank a few more Triple-A innings, and if he keeps forcing the issue, the Rangers still have time to perhaps have the right-hander make a cameo after the minor league season is over.

deGrom underwent Tommy John surgery in June of last year and is now about 14 months removed from that procedure. Once upon a time, it seemed as though deGrom would be part of a trio of heroes riding in to help the Rangers in the second half of 2024. Tyler Mahle also underwent Tommy John surgery last year and was slated for a midseason return, while Max Scherzer opened the season on the IL after undergoing offseason back surgery.

The 2023 World Series champions hoped that they could stay afloat through the first half of 2024 with a strong offense and a rotation mix consisting of Nathan Eovaldi, Jon Gray, Andrew Heaney, Michael Lorenzen, Cody Bradford, Dane Dunning and others. Ideally, they would have gotten stronger throughout the year and made a strong push in defending their title.

It hasn’t exactly played out that way, unfortunately. The team’s hitters have slashed a collective .239/.308/.381 for a 94 wRC+, putting them ahead of just seven teams in the majors. On top of that, the pitching has been a challenging carousel for the club all year. Due to various ailments, no one on the pitching staff has reached 130 innings pitched yet this year, while Eovaldi and Heaney are the only guys currently on the team with more than 100 frames. Lorenzen was traded to the Royals at the deadline and both Gray and Scherzer are currently on the IL.

The combination of injuries and some struggles around the roster have bumped the Rangers towards the back of the American League playoff race. They are 11 games back of the Astros in the West and then 12.5 games out of a Wild Card spot. The Playoff Odds at FanGraphs give them just a 0.2% chance of cracking the postseason while the PECOTA Standings at Baseball Prospectus are slightly more bullish at 0.8%.

At this point, the club is likely viewing deGrom’s return less as a spark plug for a 2024 postseason push and more about getting a few starts under his belt in preparation for the 2025 campaign. He and the Rangers signed a five-year, $185MM deal heading into 2023, though he’s only been able to make six starts on that deal so far, due to his aforementioned surgery.

The club managed to win the World Series last year even without him, but there’s still three years left on that deal, making him a key part of their next chapter. The righty has been one of the better pitchers in the world over the past decade, though the injuries have been an issue in recent years.

From 2014 to the present, he has a 2.53 earned run average in 1,356 1/3 innings pitched, striking out 31% of batters faced while only walking 5.8%. Among pitchers with at least 700 innings in that time, only Clayton Kershaw has a lower ERA while only Scherzer and Chris Sale topped deGrom in terms of strikeout rate.

In recent years, deGrom has provided even higher quality but with less quantity. He topped 200 innings from 2017 to 2019 but hasn’t even hit 100 since. The 2020 season was shortened to just 60 games by the pandemic and then deGrom missed time in the two subsequent seasons due to right side tightness, right forearm tightness and a stress reaction on his right scapula.

From 2020 to the present, he has tossed 254 2/3 innings with a 2.12 ERA and incredible 42% strikeout rate. That punchout rate is tops among all pitchers with at least 250 innings in that stretch, with Spencer Strider a distant second at 36.9%, while only reliever Emmanuel Clase bests deGrom in the ERA department.

At this point, it’s anyone’s guess what kind of form deGrom will be in when he returns. He is now 36 years old and coming off a lengthy injury absence. He also hasn’t been able to make more than 15 starts in a season since 2019.

The Rangers are set to lose both Scherzer and Heaney to free agency in a couple of months. Eovaldi could be joining them, as his deal has a conditional $20MM player option that he unlocks if he totals 300 innings pitched over 2023 and 2024 or finishes in the top five in Cy Young voting this year. Even if he unlocks that option, he might turn it down and head to the open market since he’s having a strong season and could secure a bigger guarantee over a longer deal in free agency.

If Eovaldi does depart, then the 2025 Ranger rotation on paper is deGrom, Gray, Mahle, Dunning and Bradford, with both Gray and Mahle slated for free agency after next year. Jack Leiter and Owen White are each on the 40-man roster but both have dealt with control problems.

Taken all together, deGrom’s form in the coming years figures to be a significant factor for the Rangers, considering how much they have invested in him and that there’s not a lot of long-term certainty in the rotation picture.

While things are looking promising for Verlander, Luis Garcia is more of a question mark.  The Athletic’s Chandler Rome wrote (via X) that as of Friday, Garcia hadn’t yet resumed throwing since he was shut down due to soreness over two weeks ago.  This is the second time Garcia has hit a setback in his recovery from Tommy John surgery, and since Garcia went under the knife in May 2023, a normal rehab timeline would’ve had him ready to return to the majors by this point over 15 months past his procedure date.  Though the Astros have said Garcia might return as a reliever rather than as a starter, he is running short on time to fully ramp up his readiness to rejoin Houston’s pitching staff in any capacity.

More from around the American League…

• Twins athletic trainer Nick Paparesta updated reporters (including The Athletic’s Dan Hayes) about several injured Minnesota players on Saturday, including Byron Buxton and Chris Paddack.  Buxton received a cortisone shot in his inflamed right hip and recently worked out in a pool, so Paparesta feels “we’re kind of heading in the right direction.”  This comes as a relief given Buxton’s long history of injury problems, including a more serious hip issue in 2022 that Paparesta feels may have created scar tissue related to Buxton’s current discomfort.  As for Paddack, he is set to undergo an MRI on August 27, which will be his second scan since a left forearm strain sent him to the 15-day injured list on July 17.  More will be known on Paddack’s timeline if the next MRI comes back clean, and he has already started playing games of catch in preparation to return to Minnesota’s staff before the season is over.
• Three of the Rangers’ injured veteran starters took steps in their recoveries over the weekend, as Max Scherzer threw a bullpen session today and Jacob deGrom and Jon Gray each threw three-inning simulated games on Saturday.  Gray seems to be the closest to returning, as he told MLB.com that he could return as a reliever during the Rangers’ series with the Pirates that begins tomorrow, if he isn’t lined up for a proper start during a series with the Guardians that gets underway Friday.  A right groin strain sent Gray to the 15-day IL on July 29, while deGrom could begin a Double-A rehab assignment this week in his first game action since undergoing Tommy John surgery in June 2023.  Scherzer hasn’t pitched since July 30 due to shoulder fatigue, and Texas manager Bruce Bochy said it hasn’t yet been decided if Scherzer will also embark on a rehab assignment next, or if he’ll first take part in a live batting practice session.
• Tarik Skubal had another quality start tonight in the Tigers’ 3-2 win over the Yankees, as the star southpaw limited New York to one run (on three hits and four walks) over six innings of work.  Skubal is up to a career-high 155 1/3 innings pitched, and manager A.J. Hinch told MLB Network’s Jon Morosi and other reporters that Sunday “could very well be his last start on regular rest” this season.  Since Detroit is all but out of the wild card race, the team has no real reason to put too many extra miles on Skubal’s arm, though naturally the team isn’t going to shut him down completely as he pursues the AL Cy Young Award.

If all goes well, Verlander would likely be activated for the start of the Astros’ series with the Orioles that begins on August 22.  Verlander would become the sixth member of a six-man rotation Houston is planning to deploy during a busy stretch of the schedule, as after receiving three off-days within the first 15 days of August, the Astros then play every day from August 16 through September 2.  Assuming Verlander returns in his usual top-of-the-rotation form, he’ll be a giant boost to a Houston team that is battling the Mariners for the AL West title, and will again be looking to make another deep playoff run.  Between this neck problem and a season-opening bout of shoulder inflammation, Verlander has been limited to 57 innings in his 19th Major League season, but he has a solid 3.95 ERA when available to pitch.

More from around the AL West…

• Julio Rodriguez hasn’t played July 21 due to a high ankle sprain, but the Mariners outfielder has been taking part in some moderate-intensity running exercises as part of his recovery process.  Manager Scott Servais told MLB.com and other media earlier this week that Rodriguez’s injury is viewed as a day-to-day situation by the team, as Rodriguez might be activated from the 10-day injured list without the need for a rehab assignment.  “The swinging really isn’t the issue, from what [Rodriguez] said.  It’s just more of the running and trying to get up to speed and taking the turns, things like that,” Servais noted.  As such, Seattle could try using Rodriguez as a designated hitter if the team wants to take it easy on his ankle.  The uncertain nature of high ankle sprains and the lack of a timetable makes it unclear when J-Rod might be back in action, but it could technically be as early as this coming week if he shows quick improvement and is able to run passably well.
• Jacob deGrom threw a live batting practice on Thursday, with Rangers skipper Bruce Bochy telling reporters (including Evan Grant of the Dallas Morning News) that deGrom will have another live BP session during the Rangers’ upcoming August 12-14 series in Boston.  This is the first time deGrom had faced live hitters during his rehab from a June 2023 Tommy John surgery, and the four-time All-Star remains on pace with the standard 13-14 month recovery timeline.  Since he’ll have a third bullpen session and then a minor league rehab assignment, deGrom might not return to the Texas roster before the end of August, but the veteran should be able to log some big league innings before 2024 is out, and gain some peace of mind about his health heading into the offseason.

What once was a starting pitching hodgepodge looks increasingly enviable. If Mahle is cleared to return after today’s start, he’ll join Scherzer, Nathan Eovaldi, Jon Gray, Michael Lorenzen, Andrew Heaney and Dunning as viable rotation options, with Bradford in the bullpen and deGrom looming on the horizon. That’s nine MLB-caliber starters, to say nothing of veteran starter Jose Ureña (who started six games but is in the bullpen presently).

With so many options suddenly at their fingertips, there’s been plenty of speculation about the Rangers trading from that stockpile of arms — even as they narrow the deficit in the postseason hunt. Texas has won four straight games. The Mariners have lost three straight. The Rangers now sit only three games back of the first-place Astros in the West and are just 5.5 games out in the Wild Card hunt. They’re not going to operate as a pure seller, but Ken Rosenthal of The Athletic suggests that Lorenzen or perhaps even Gray could be moved before Tuesday’s trade deadline.

Lorenzen, 32, signed with the Rangers on a one-year, $4.5MM deal in spring training. It was a bargain price for a veteran righty coming off a solid season, and he’s proven to be well worth the investment. He’s pitched 97 innings over the course of 17 starts and turned in a 3.53 ERA. Lorenzen’s 18.5% strikeout rate and 11.6% walk rate both leave plenty to be desired and point to some likely ERA regression, but he’s been precisely the type of veteran rotation stabilizer the Rangers hoped to be acquiring when signing him.

As of deadline day, Lorenzen will have just $1.5MM of that base salary yet to be paid out. He’s already picked up $800K of innings-based incentives and will get another $200K when he reaches 100 innings, likely in his next start. Assuming that comes with the Rangers — he’s their probable starter Saturday — a new team would be on the hook for the remaining portion of his base and additional incentives he’d unlock by reaching 120 innings ($300K), 140 innings ($350K), 160 innings ($400K) and 180 innings ($450K). He’s on pace to barely reach that final milestone.

At most, a team adding Lorenzen would pay around $1.5MM in base salary and an additional $1.5MM worth of incentives. If Lorenzen is pitching well enough to reach that 180-inning mark, it’d be considered money well spent. If nothing else, a budget-conscious team looking to add a stable starter (e.g. Twins, Guardians) could view Lorenzen as an affordable option.

Gray would be a more surprising trade candidate. He’s in the third season of a four-year, $56MM contract that’s paying $13MM both this year and next. Thus far, he’s posted 94 innings of 3.73 ERA ball on the season. While Gray’s 19.7% strikeout rate is the lowest of his career (aside from the shortened 2020 season), his 5.8% walk rate is a career-best mark. He’s still averaging 95 mph with his heater, while his opponents’ chase rate and swinging-strike rate are roughly in line with his 2022-23 marks.

Rosenthal also cites a pair of names the Rangers would prefer to hang onto even as they ponder trading from their rotation depth: Eovaldi and Heaney. The former is well on his way to vesting a $20MM player option for the 2025 season. That option would decrease his trade value — a new team would be stuck with the $20MM in the event of a major, post-trade injury. Beyond that, Eovaldi has been one of the team’s best arms this season, notching a 3.31 ERA, 24.6% strikeout rate and 6.1% walk rate in 106 innings. He’d likely be ticketed for their playoff rotation, should they get there. And, even if they don’t, the Rangers might simply hope Eovaldi stays healthy and enjoys pitching in his home state enough that he’d pick up that player option for the 2025 season.

As for Heaney, he’s turned things around after a shaky first season in Texas. The veteran southpaw boasts a 3.60 ERA, 23.5% strikeout rate and 6.8% walk rate in exactly 100 innings. He’s a free agent at season’s end, so one would imagine he’s an on-paper trade candidate in this scenario where Texas deals from its excess. However, the Rangers don’t have an established left-hander in their bullpen. Brock Burke was excellent in 2022 but took a step back in ’23 and was optioned earlier this season after being shelled through 9 2/3 innings. Rookie Jacob Latz has a solid 3.68 ERA in 36 2/3 innings, but he’s walked 13.5% of his opponents. Bradford could possibly fill that role, but he’s yet to return from a stress reaction in his ribcage.

Heaney has experience pitching both as a starter and reliever, including during his time with Texas. He’s throwing well right now but would likely be pushed out of a theoretical postseason rotation. In that setting, he could slide into the bullpen and match up against tough lefties and/or provide multiple innings in long relief.

To the extent there’s a silver lining of Monday for Ranger fans, it’s that the team provided some good news on the injury front. Manager Bruce Bochy told reporters that Max Scherzer’s next start will come at the major league level (X link via Jeff Wilson of Rangers Today). While Bochy didn’t specify a date for the future Hall of Famer’s season debut, it seems likely to fall during this weekend’s series against the Royals.

A herniated disc sent Scherzer to the operating table last December. The initial recovery timeline called for a June or July return. Scherzer seemed to be ahead of schedule early in the year before discomfort in his right thumb slowed his progress. The three-time Cy Young winner restarted a rehab stint on June 9. He pitched twice with Triple-A Round Rock, logging 79 pitches across 4 2/3 innings on Saturday.

Texas has a starting five of Nathan Eovaldi, Jon Gray, Michael Lorenzen, Dane Dunning and Andrew Heaney. Unless Texas opts for a six-man rotation, Scherzer’s return will bump someone from that group to the bullpen. It certainly won’t be Eovaldi or Gray. The Rangers signed Lorenzen to fill a sixth starter/swing role, but he has turned in a 2.86 ERA while working six innings per appearance through 11 starts. Even with middling strikeout and walk numbers, Lorenzen has probably pitched his way into a long-term rotation spot.

Heaney, who’ll take the ball against the Mets on Wednesday, has started 13 of 14 appearances. The southpaw owns a 4.19 ERA with a decent 21.4% strikeout percentage and a strong 6.2% walk rate — similar numbers to those he turned in during his first season in Arlington. Dunning has had a tougher go this season, allowing 4.73 earned runs per nine. While his 26.7% strikeout rate narrowly leads Texas starters, the University of Florida product has issued walks at an uncharacteristic 11.6% clip while struggling with the home run ball.

Scherzer has been joined on the injured list all season by Tyler Mahle and Jacob deGrom. Mahle began facing hitters earlier this month as he works back from last May’s Tommy John procedure. deGrom, who underwent the same surgery in early June 2023, isn’t too far behind. He hit a milestone in his rehab on Monday, throwing off a mound for the first time in 12 months (X link via Shawn McFarland of the Dallas Morning News). deGrom has been targeting a return to MLB action at some point in August.

It appears things are going well in the early stages of Scherzer’s rehab process. Manager Bruce Bochy told MLB Network this week the team envisions the star righty being back on an MLB mound by June (X link). The veteran skipper said that’s “a little bit earlier” than the team initially expected. Bochy indicated the club was shooting for a July return for offseason signee Tyler Mahle and a potential August timetable on Jacob deGrom, both of whom are working back from Tommy John procedures.

A few other health notes around the league:

• Brendan Donovan is preparing for a rebound after his 2023 season was cut short. An injury to his throwing arm initially required the Cardinals infielder to move to designated hitter. With the team out of contention by the trade deadline, Donovan shut things down and underwent season-ending surgery. While that was initially reported as a flexor tendon repair in his forearm, Donovan clarified to John Denton of MLB.com that he actually had an internal brace procedure to fix the UCL in his elbow (on X). The 27-year-old is back in action this spring and should split most of his time with Nolan Gorman between second base and DH.
• Reds starter Nick Lodolo was limited to seven appearances in 2023 because of a stress reaction in his left tibia. That bothersome issue kept him out of action from mid-May on. The southpaw apparently isn’t quite at 100%. Lodolo has yet to make his Spring Training debut because of residual leg discomfort on days after his bullpen or live batting practice sessions, manager David Bell told reporters (link via Gordon Wittenmyer of the Cincinnati Enquirer). The Reds are sending Lodolo for additional testing on the bone before deciding on the next step in his build-up process. That’s at least somewhat alarming, although Bell said the team is still hopeful that Lodolo will avoid opening the season on the injured list.
• The Rays lost one of their depth infielders to what’ll be a fairly significant injury. Yu Chang will be out six to eight weeks after suffering an oblique strain, manager Kevin Cash told Marc Topkin of the Tampa Bay Times (relayed on X). That was the concern when the team revealed that Chang was dealing with left side soreness earlier in the week. The defensive specialist is in camp on a minor league contract. He had a shot at securing an Opening Day bench spot, particularly with Taylor Walls opening the season on the IL, but that’s no longer in play. The Rays have declared José Caballero their expected starter at shortstop. Recent free agent pickup Amed Rosario is on hand as a multi-positional option who’d likely be Caballero’s primary backup.

Junis, 31, defied the odds as a 29th-round pick by the Royals in the 2011 draft and managed to make the majors during the 2017 season. In the years since then, the right-hander has managed to put together a solid career while swinging between the bullpen and the rotation for both Kansas City and San Francisco. While he typically offered roughly league average production for most of his career, Junis enjoyed a career year with the Giants this past season as he pitched to a 3.87 ERA with a 3.74 FIP in 86 innings of work. In 40 appearances for San Francisco last year, Junis struck out a career-best 26.2% of batters faced while walking just 5.7%.

Impressive as Junis was last season, the right-hander is unlikely to be an impactful addition to the Red Sox rotation mix if signed as he tended to pitch most effectively in shorter bursts last year. The righty surrendered a 5.32 ERA in 31 innings of work across nine appearances where he threw 50 pitches or more last year. By contrast, Junis posted a strong 2.95 ERA across 39 2/3 innings of work in 26 appearances where he threw 40 pitches or less. Junis’s success in shorter appearances could make him an interesting relief option for the Red Sox, particularly if the club parts with closer Kenley Jansen before Opening Day.

Heuer, meanwhile, would be more of a speculative addition by the Red Sox. The right-hander last pitched in the majors back in 2021 due to Tommy John surgery and a fractured elbow, but sports a solid 3.56 ERA and 3.66 FIP across 91 innings of work in the majors between the White Sox and Cubs. The righty was nothing short of dominant for the south siders during the 2020 season in particular, as he paired a 50% groundball rate with a upper-90s heater that allowed him to strike out 27.2% of batters faced in 21 appearances. The Cubs non-tendered Heuer earlier this offseason, likely thanks to his two-year layoff from pitching while rehabbing from multiple elbow issues. Still, the 27-year-old hurler has flashed set-up caliber skills during his limited big league appearances and could be a savvy add to the Boston bullpen if healthy.

More from around the American League…

• The Twins are lacking in starting pitching depth after losing right-handers Sonny Gray, Kenta Maeda, and Tyler Mahle in free agency earlier this winter, and GM Thad Levine acknowledged that concern during a recent appearance on MLBNetwork Radio. During the appearance, Levine noted that the club feels comfortable with its current starting five of Pablo Lopez, Joe Ryan, Bailey Ober, Chris Paddack, and Louie Varland, but that hasn’t stopped the club from exploring both the trade and free agent markets for other rotation options. Bolstering the club’s rotation mix would not only provide the club with much-needed depth to safeguard against injury but could also give Varland competition for the fifth-starter role, allowing him to return to the multi-inning bullpen role in which he thrived late last season. Michael Lorenzen, Mike Clevinger, and Hyun Jin Ryu are among the mid-level rotation options still available this winter.
• Rangers right-hander Jacob deGrom made just six starts for the reigning World Series champions before undergoing Tommy John surgery last spring, but optimism remains at the oft-injured ace will be able to contribute to the club at some point during the 2024 campaign. As noted by Shawn McFarland of the Dallas Morning News, deGrom provided a health update to reporters during the club’s FanFest this weekend. The righty indicated that his arm is feeling good seven months removed from going under the knife and that he currently plans to begin throwing again “sometime this spring.” While deGrom did not mention a timetable for his return to the big league mound, the update tracks with previous comments from the right-hander back in October, which indicated he was targeting a return to the majors in August of 2024. Among the most talented pitchers of his generation, it’s hard to overstate the potential impact deGrom could have for the Rangers this year if he’s available for the stretch run and a potential playoff push. Over his past 108 starts dating back to the 2018 season, deGrom has posted a 2.08 ERA with a near-matching 2.11 FIP and a whopping 921 strikeouts in just 675 2/3 innings of work.

Fortunately, it appears that deGrom’s rehab process is going rather well. A typical timeline for a pitcher in deGrom’s situation would be somewhere between 14 and 18 months before returning to a big league mound but deGrom expressed optimism that he could return to the Rangers at the earlier end of that window, with August 2024 as a stated goal. Of course, there’s a long road ahead to reach that point, though Sherman notes that deGrom has regained full range of motion at this point and will be able to return to throwing shortly after the new year, with a mound in sight come Spring Training.

If deGrom is indeed healthy and effective come the stretch run in 2024, he’d surely provide a massive boost to a Rangers club that dominated for much of the 2023 regular season and has seemingly found a second wind during the postseason in spite of a difficult stretch run that saw the club slow to a 38-33 record in the second half this season. Ignoring any possible offseason additions, deGrom would return to a 2024 rotation group that projects to feature former Mets co-ace Max Scherzer, veterans Nathan Eovaldi and Jon Gray, southpaw Andrew Heaney, and right-hander Dane Dunning. When on the mound for the Rangers this year, deGrom was nothing short of excellent with a 2.67 ERA and 1.54 FIP across six starts. His current contract runs through the end of the 2027 season, with a 2028 club option that triggered as a result of him undergoing Tommy John surgery earlier this year.

More from around the state of Texas…

• Sticking with the Rangers, manager Bruce Bochy spoke to reporters this afternoon regarding tomorrow’s Game 3 of the ALCS, where Scherzer is expected to take the mound in a competitive setting for the first time in over a month due to a teres major strain. While Bochy didn’t specify whether or not Scherzer would have any sort of limitations on him headed into tomorrow’s game, Cody Stavenhagen of The Athletic relayed that Bochy referred to 70 pitches as a “baseline” for Scherzer. That’s in line with his previously reported 68-pitch simulated game prior to the ALCS. If Scherzer is indeed limited in some capacity during tomorrow’s game, the Rangers have plenty of long relief options available to them, including Cody Bradford and Martin Perez.
• Meanwhile, Astros manager Dusty Baker spoke to reporters (including The Athletic’s Chandler Rome) this afternoon regarding the club’s plans for the remainder of the ALCS, in which they trail their division rival 0-2. Baker noted that he’s spoken to outfielder Kyle Tucker about a potential move down the batting order, though he emphasized that such a move would be temporary. It’s been a rough postseason for Tucker, as the 26-year-old has gone hitless in the ALCS so far after slashing just .143/.294/.214 in 17 trips to the plate against the Twins during the ALDS. Baker did not, however, indicate whether or not the club is considering turning to veteran ace and future Hall of Famer Justin Verlander on short rest for Game 4, saying that the club hasn’t discussed the possibility yet. Verlander would be on three days of rest for Game 4, a situation in which the Astros have used him in the playoffs before. As Rome notes, Verlander struggled against the Rays in Game 4 of the ALDS back in 2019 on three days of rest, allowing four runs in 3 2/3 innings of work.

This week, host Darragh McDonald is joined by Steve Adams of MLB Trade Rumors to discuss:

• The promotion of Elly De La Cruz (2:05)
• The demotion of Alek Manoah (9:15)
• Tommy John surgery for Jacob deGrom (14:40)
• Our new series highlighting the best recent trade returns on rental players (19:10)

Plus, we answer your questions, including:

• If Kevin Kiermaier can stay healthy and remain productive, what kind of contract is he looking at in free agency? (22:20)
• Could Corbin Burnes realistically be traded by the deadline? If so, what teams would likely make a push for him? (26:50)
• What could the Cubs do with Marcus Stroman? (30:45)

Check out our past episodes!

• The Wide-Open NL Wild Card Race, Returning Pitchers and Cast-Off Veterans – listen here
• The Mets are turning things around, and how serious are the Mariners, Marlins and Diamondbacks? – listen here
• The Cardinals’ U-Turn on Willson Contreras, Mitch Keller’s breakout, and the state of the Padres – listen here

The news is obviously terrible news for deGrom, the Rangers and the baseball world at large. deGrom, who turns 35 later this month, had established himself as arguably the best pitcher alive with the Mets in his career. From 2014 to 2020, he tossed 1169 2/3 innings with a 2.61 ERA, 29.2% strikeout rate, 6.1% walk rate and 45.1% ground ball rate. He won back-to-back Cy Young Awards in 2018 and 2019, tossing over 200 innings in each campaign with a 1.70 ERA in the former and a 2.43 mark in the latter.

The narrative since that time, however, has been dominating by concerns around his health. In 2021, he had a miniscule 1.08 ERA through 15 starts but landed on the injured list due to some forearm tightness. There seemed to be some disagreement about the nature of his injury, as Mets president Sandy Alderson said that deGrom had been dealing with a low-grade tear in the UCL in his pitching elbow, though deGrom insisted his ligament was “perfectly fine.”

That was a concerning set of statements in its own right, but especially so considering that deGrom had previously undergone TJS as a prospect. He didn’t return at any point in that 2021 season but seemed to be healthy coming into 2022. He then suffered a stress reaction in his scapula during Spring Training and missed more time but was eventually able to return in August of last year. He made 11 starts for the Mets down the stretch and another in the postseason, finishing the season healthy. He had a 3.08 ERA in those regular season starts, striking out 42.7% of opponents against a walk rate of just 3.3%.

deGrom still had one year and $30.5MM remaining on his contract, as well as a club option for 2024, but had long maintained that he intended to trigger his opt-out and test free agency. He did just that and eventually landed a five-year, $185MM deal with the Rangers. He made six starts for the club here in 2023 with a 2.67 ERA but landed on the injured list at the end of April due to elbow inflammation. He was transferred to the 60-day IL yesterday, which didn’t necessarily portend doom since he had already been out of action for over a month. But now the full truth has been revealed and it was an ominous sign after all.

The Rangers are off to a great start here this year, currently 39-20 and leading the American League West. Still, they were undoubtedly hoping to have deGrom’s elite skills back on the roster for a late-season playoff race and theoretical postseason appearance. But they will now have to proceed without him in those plans. Currently, the rotation consists of Martín Pérez, Andrew Heaney, Nathan Eovaldi, Jon Gray and Dane Dunning. Today’s likely increases the chances that they look for rotation upgrades this summer, though their ultimate appetite for a move like that will depend on the health and performance of the remaining members.

For deGrom, this news will have an impact on his contract, specifically related to the conditional option for 2028. The contract states that, if he undergoes Tommy John surgery or has an elbow or shoulder injury that leads to an absence of 130 days in a single season or a full calendar year absence over multiple seasons, a club option will kick in. It’s valued at $20MM but could jump to $30MM if deGrom has a top five finish in Cy Young voting at any point or tallies 625 innings over the course of the deal. It would go up to $37MM if he gets in the top five of Cy Young voting three times or gets to 725 frames. If he didn’t have a significant injury, he could have vested that $37MM figure by tossing just 160 innings in 2027 and getting a top five finish in Cy Young voting that year.

Now the major question for deGrom will be how he bounces back in 2024 and beyond. Coming back from a Tommy John surgery and succeeding isn’t unprecedented, even for a relatively older pitcher like deGrom. Just last year, Justin Verlander came back from the procedure and had Cy Young-winning season for the Astros at the age of 39. deGrom will be turning 35 in about two weeks and will therefore be about 36 when he’s attempting to come back. That makes him a couple of years younger than Verlander was but it’s not exactly the same situation since that was Verlander’s first TJS and this will be a second for deGrom, which tends to have a lower success rate at returning pitchers to their previous states.

In time, more information will surely be forthcoming about deGrom’s progress and how the Rangers plan to proceed without him. But the unavoidable fact of today is that one of the best pitchers in baseball will be out of action for at least a year and possibly even longer.

At this point, it’s unclear if anything has meaningfully changed in deGrom’s timeline. He has already been on the injured list since April 29 due to inflammation in his throwing elbow and had yet to begin a rehab assignment. Today’s transfer officially rules him out until 60 days from that initial IL placement, meaning he could be reinstated as soon as June 28. Even if he were cleared to start ramping up his pitch count tomorrow, he likely would have needed a few weeks to get back to a full starter’s workload anyway. It’s possible that this is merely a procedural move and that his health status hasn’t changed. If there has been some kind of setback, that information has yet to be publicly revealed. He will have a follow-up MRI this week, per Evan Grant of the Dallas Morning News.

Health has been the major question mark surrounding deGrom in recent years. Arguably the best pitcher on the planet when healthy, it’s been quite some time since he remained on the mound for an extended period of time. He logged over 200 innings in each season from 2017 to 2019, but then the pandemic-shortened 2020 season kept him to just 68 frames. In 2021, he went on the injured list with forearm tightness in July of 2021 and never returned. He then missed the start of 2022 due to a stress reaction in his shoulder blade, returning in August after missing over a year of action.

He was still excellent when on the mound, posting a tiny 2.05 ERA over that 2020 to 2022 stretch, striking out 42.4% of opponents against a 4.5% walk rate. The pandemic was obviously unrelated, but it nonetheless combined with the injuries to limit him to 224 1/3 innings over those three years. The Rangers made a bet on him by signing him to a five-year, $185MM deal this winter. He made six starts for his new club with a 2.67 ERA but has been on the shelf since then with an uncertain outlook.

Howard, 26, has been on the injured list all year after suffering a lat strain during the spring. He recently began a rehab assignment and pitched two scoreless relief outings. Howard had the #27 slot on Baseball America’s top 100 list in both 2020 and 2021 while with the Phillies. Unfortunately, he hasn’t been able to put it all together in the big leagues just yet. Coming over to the Rangers in a 2021 deadline deal, he has 111 1/2 major league innings between the two clubs with a 7.09 ERA.

The righty had a chance to establish himself as a future rotation building block last year, as he was one of several younger hurlers given a shot in the Texas rotation. Unfortunately, he spent much of the year either in the minors or on the injured list, only tossing 37 2/3 innings in the majors with a 7.41 ERA. The club then totally revamped their rotation this winter by re-signing Martín Pérez and acquiring deGrom, Andrew Heaney, Nathan Eovaldi and Jake Odorizzi to slot alongside incumbent Jon Gray.

Odorizzi is done for the year due to a shoulder procedure and deGrom is obviously not an option for a while, but it still seems as though Howard has been pushed out of the rotation mix, at least for now. His recent rehab assignment could have been as long as 30 days and allowed him to get stretched out but he’s instead been reinstated after just a couple of short outings. That doesn’t mean the book has totally closed on him being a starter but he is in his final option year. With the Rangers’ bullpen having posted a collective 4.47 ERA on the season, perhaps they would like to take some time to see if he can be of use to them in a relief capacity.

One of the struggling members of the relief corps has been Hernández. He posted a solid 2.90 ERA in 2020 but required Tommy John surgery in April of 2021, wiping out that entire season. He returned last year and was able to make 29 appearances with a 2.97 ERA. Unfortunately, his results have taken a big dip here in 2023, as he currently has a 6.65 ERA through 25 outings.

The remaining months of the season will be important for the righty as he has just one option year left, meaning he’ll be out of options next year as long as he spends at least 20 days in the minors this season. His trajectory for free agency could also potentially be impacted as he came into this campaign with three years and 41 days of service time. Spending roughly a couple of months in the minors would prevent him from getting to the four-year mark this season and delay his free agency by a year. He could also wind up as a non-tender candidate if he’s out of options and his results don’t improve.

Urias’s setback opens the door for young right-hander Bobby Miller to make another start after the 24-year-old top prospect threw five innings of one-run ball against a tough Braves lineup in his MLB debut earlier this week. With Miller looking effective, there’s plenty of reason for the Dodgers to proceed cautiously with their staff ace as he works his way back from his current hamstring ailment. Urias entered the 2023 campaign with a career ERA of just 2.82 (148 ERA+), but his platform season before he’s slated to test free agency in the offseason hasn’t gotten off on the same dominant foot as usual. Through ten starts this season, Urias has posted a surprisingly pedestrian 4.39 ERA (101 ERA+) with a worrisome 5.31 FIP. That season line is weighed down by a final brutal stretch of six starts immediately preceding Urias’s placement on the IL, where he posted a 6.25 ERA and 6.86 FIP in 31 2/3 innings of work.

More from around MLB’s West divisions…

• Rangers ace Jacob deGrom has been on the injured list with elbow inflammation for a month now, as the club has taken their oft-injured ace’s ramp-up back to game action slowly. After throwing a 25-pitch, fastball-only bullpen session last week, deGrom progressed to a 31-pitch bullpen session yesterday per MLB.com, during which he began to mix in sliders and change-ups. Manager Bruce Bochy noted that deGrom will be evaluated over the coming days as he recovers from the session while the club attempts to establish a clearer timeline for his return. As arguably the best pitcher in the world when healthy it’s hard to overstate the value deGrom, who has posted a 2.67 ERA and 1.57 FIP in his first six starts as a member of the Rangers, has for the club. Nonetheless, Texas has been able to excel even without their ace thanks to excellent performances from Nathan Eovaldi, Jon Gray, and Martin Perez.
• Padres shortstop Xander Bogaerts is out of the lineup today while the 30-year-old star deals with discomfort in his wrist. As noted by Kevin Acee of the San Diego Union-Tribune, the issue is in the same wrist that required a cortisone shot during spring training. Acee notes that it’s still too soon for Bogaerts to receive another shot, so the shortstop has opted to instead play through the discomfort on and off throughout the season. The discomfort could help to explain Bogaerts’s struggles this past month, as he has slashed just .195/.290/.268 in 21 games so far in May. Acee notes that the hope is that Bogaerts will be able to return to the lineup tomorrow, but the situation appears to be day-to-day.